Items tagged with Drug-susceptible TB

New clinical practice guidelines: Treatment of drug-susceptible TB (post with simple image)

Jointly developed by the American Thoracic Society, U.S. Centers for Disease Control and Prevention and Infectious Diseases Society of America.

Are pretomanid-containing regimens for TB a victory or a victory narrative? (post with simple image)

"Given the evidence base available to us currently, can we claim pretomanid a victory? We think more research is needed before pretomanid can be celebrated as a promising treatment for people with tuberculosis."

Landmark TB trial identifies shorter-course treatment regimen (post with simple image)

Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.

SHINE trial on shorter treatment for children with minimal TB (post with simple image)

TB treatment can be shortened from six to four months in 80% of children.

Landmark TB trials results published in New England Journal of Medicine (post with simple image)

A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.

Page 3 of 3 · Total posts: 0

←First 2 3